1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports advanced translational research that will foster the transformation of promising ideas in lung cancer into clinical applications. Preliminary lung cancer relevant data required.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligibility will be outlined in the final funding opportunity announcements. Preliminary lung cancer relevant data is required. Focus on relevance to military health. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1.35M over 3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
FY26 Lung Cancer Research Program (LCRP) Translational Research Award (Level 1) is funded by Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Translational Research Award (FY26 LCRP) is sponsored by U.S. Army Medical Research Acquisition Activity (USAMRAA). This award supports innovative lung cancer research from advanced preclinical studies to pilot clinical trials, aiming to translate discoveries into clinical practice. While focused on lung cancer, the translational and clinical trial aspects align with cancer immunotherapy clinical research.
Lung Cancer Research Program (LCRP) Translational Research Award (TRA) (FY26) is sponsored by Defense Health Agency Contracting Activity (DHACA). This award supports advanced translational research that will foster the transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article